Muvon
Joint statement by the leading patient group WFIPP and MUVON Therapeutics AG
Today, the World Federation of Incontinence and Pelvic Problems (WFIPP) released a statement of partnership and collaboration with...
Search
Muvon
- Apr 21
- 1 min
MUVON Therapeutics is supported by the Lichtsteiner Foundation
MUVON Therapeutics was selected by the Lichtsteiner Foundation to become a part of their supported community of pioneering innovators....
85 views0 comments
Muvon
- Apr 19
- 1 min
MUVON's CEO Deana Mohr featured in Top 30 In Vivo's Rising Leaders 2022
MUVON Therapeutics, a spin-off from the University of Zurich developing a platform technology for the regeneration of skeletal muscle...
162 views0 comments
Muvon
- Feb 10
- 1 min
CEO Deana Mohr presented MUVON in interview for BioInnovation Spotlight
Our CEO Deana Mohr had the great opportunity to present MUVONs vision and innovative regenerative cell therapy in an interview for...
99 views0 comments
Muvon
- Jan 27
- 1 min
Translation and automation hurdles for cell therapies
Informative article published in BioInsights, written by our CSO Jenny Prange and our innovation manager Beatrix Rauch Schmid. This...
105 views0 comments
Muvon
- Sep 27, 2021
- 1 min
MUVON wins second place at IFAS Innovation Challenge 2021
MUVON Therapeutics was selected as one of twelve finalists for 2021's IFAS Innovation Challenge and placed second in the final pitching...
86 views0 comments
Muvon
- Jun 10, 2021
- 1 min
Deana Mohr wins spot in Venture Leaders Medtech 2021
MUVON Therapeutics CEO Deana Mohr was selected as one of ten Venture Leaders in Medtech to represent the Swiss National Startup Team in...
163 views0 comments
Muvon
- Jun 2, 2021
- 1 min
MUVON featured by Startupticker
MUVON was featured in an article by Startupticker describing our regenerative approach for the treatment of incontinence and the progress...
49 views0 comments
Muvon
- Apr 29, 2021
- 1 min
MUVON Therapeutics selected as finalist for the 2021 >>venture>> Startup Competition
MUVON is excited to have been selected as one of the top 10 startups in the Health and Nutrition vertical of the 2021 >>venture>> startup...
73 views0 comments
Muvon
- Apr 21, 2021
- 1 min
MUVON Therapeutics selected for Tech4Eva accelerator program
MUVON Therapeutics is proud to have been selected as one of 30 start-ups and projects from around the world to join Switzerlands first...
41 views0 comments
Muvon
- Apr 8, 2021
- 1 min
Greater Zurich Area features MUVON Therapeutics in article on successful biotech innovations
The University of Zurich (UZH) is advancing biotechnology with innovations. Thanks to a systematic support system and the dynamic...
77 views0 comments
Muvon
- Apr 1, 2021
- 1 min
MUVON is being accelerated by Wyss Zurich
MUVON Therapeutics is proud to announce the acceptance as a Wyss Zurich Project starting April 2021. The Wyss Zurich is a joint...
90 views0 comments
Muvon
- Jan 20, 2021
- 1 min
Modern Therapy of Urinary Incontinence Using Muscle Stem Cells (Article in German)
Abstract: Urinary incontinence affects a large number of patients, and the cost of treatment continues to rise with the demographic...
209 views0 comments
Muvon
- Dec 21, 2020
- 1 min
The Beginning of the MUVON Story
In October 2020 MUVON Therapeutics Ltd. was founded. The technology behind MUVON was developed over the past decade at the University of...
76 views0 comments
Muvon
- Jun 26, 2020
- 1 min
Muscle Precursor Cells for the Restoration of Irreversibly Damaged Sphincter Function
Abstract Multiple modalities, including injectable bulking agents and surgery, have been used to treat stress urinary incontinence....
111 views0 comments
Muvon
- Jun 25, 2020
- 1 min
The role of donor age and gender in the success of human muscle precursor cell transplantation
Abstract Autologous cell transplantation for the treatment of muscle damage is envisioned to involve the application of muscle precursor...
40 views0 comments